{
  "trial_id": "NCT04576988",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, baseline 6-minute walk distance (6MWD), pulmonary vascular resistance (PVR), pulmonary capillary wedge pressure (PCWP), left ventricular end-diastolic pressure, WHO Functional Class (FC), background PAH therapy, diuretic use, hemoglobin levels, platelet count, systolic blood pressure, diastolic blood pressure, estimated glomerular filtration rate (eGFR), serum alanine aminotransferase levels, aspartate aminotransferase levels, total bilirubin levels, forced vital capacity (FVC), history of interstitial lung disease (ILD), history of obstructive sleep apnea, left ventricular ejection fraction, history of coronary disease events, history of cerebrovascular accident, history of heart failure, mitral regurgitation, aortic regurgitation, use of intravenous inotropes.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "6-Minute Walk Distance (6MWD) at baseline",
          "baseline 6-minute walk distance (6MWD)"
        ],
        [
          "World Health Organization (WHO) functional class (FC) II or III at baseline",
          "WHO Functional Class (FC)"
        ],
        [
          "Background PAH Therapy at Baseline",
          "background PAH therapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "pulmonary vascular resistance (PVR)",
        "pulmonary capillary wedge pressure (PCWP)",
        "left ventricular end-diastolic pressure",
        "diuretic use",
        "hemoglobin levels",
        "platelet count",
        "systolic blood pressure",
        "diastolic blood pressure",
        "estimated glomerular filtration rate (eGFR)",
        "serum alanine aminotransferase levels",
        "aspartate aminotransferase levels",
        "total bilirubin levels",
        "forced vital capacity (FVC)",
        "history of interstitial lung disease (ILD)",
        "history of obstructive sleep apnea",
        "left ventricular ejection fraction",
        "history of coronary disease events",
        "history of cerebrovascular accident",
        "history of heart failure",
        "mitral regurgitation",
        "aortic regurgitation",
        "use of intravenous inotropes"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline 6-Minute Walk Distance (6MWD), WHO Functional Class, Pulmonary Vascular Resistance (PVR), Pulmonary Capillary Wedge Pressure (PCWP), Background PAH Therapy, Hemoglobin, Platelet Count, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR), Serum Alanine Aminotransferase, Serum Aspartate Aminotransferase, Total Bilirubin, Forced Vital Capacity (FVC), Left Ventricular Ejection Fraction (LVEF),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "6-Minute Walk Distance (6MWD) at baseline",
          "Baseline 6-Minute Walk Distance (6MWD)"
        ],
        [
          "World Health Organization (WHO) functional class (FC) II or III at baseline",
          "WHO Functional Class"
        ],
        [
          "Background PAH Therapy at Baseline",
          "Background PAH Therapy"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Pulmonary Vascular Resistance (PVR)",
        "Pulmonary Capillary Wedge Pressure (PCWP)",
        "Hemoglobin",
        "Platelet Count",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Serum Alanine Aminotransferase",
        "Serum Aspartate Aminotransferase",
        "Total Bilirubin",
        "Forced Vital Capacity (FVC)",
        "Left Ventricular Ejection Fraction (LVEF)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, 6-Minute Walk Distance, Pulmonary Vascular Resistance, Pulmonary Capillary Wedge Pressure, World Health Organization Functional Class, Background PAH Therapy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "6-Minute Walk Distance (6MWD) at baseline",
          "6-Minute Walk Distance"
        ],
        [
          "World Health Organization (WHO) functional class (FC) II or III at baseline",
          "World Health Organization Functional Class"
        ],
        [
          "Background PAH Therapy at Baseline",
          "Background PAH Therapy"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Pulmonary Vascular Resistance",
        "Pulmonary Capillary Wedge Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), WHO functional class, 6-minute walk distance (6MWD), pulmonary vascular resistance (PVR), pulmonary capillary wedge pressure (PCWP) or left ventricular end-diastolic pressure, hemoglobin, platelet count, systolic and diastolic blood pressure, estimated glomerular filtration rate (eGFR), serum alanine aminotransferase, aspartate aminotransferase, total bilirubin levels, forced vital capacity (FVC), left ventricular ejection fraction, medical history (including PAH diagnosis, comorbidities, and concomitant medications).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "6-Minute Walk Distance (6MWD) at baseline",
          "6-minute walk distance (6MWD)"
        ],
        [
          "World Health Organization (WHO) functional class (FC) II or III at baseline",
          "WHO functional class"
        ],
        [
          "Background PAH Therapy at Baseline",
          "medical history (including PAH diagnosis, comorbidities, and concomitant medications)"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "pulmonary vascular resistance (PVR)",
        "pulmonary capillary wedge pressure (PCWP) or left ventricular end-diastolic pressure",
        "hemoglobin",
        "platelet count",
        "systolic and diastolic blood pressure",
        "estimated glomerular filtration rate (eGFR)",
        "serum alanine aminotransferase",
        "aspartate aminotransferase",
        "total bilirubin levels",
        "forced vital capacity (FVC)",
        "left ventricular ejection fraction"
      ]
    }
  }
}